Director Shareholding
2008年7月11日 - 4:44PM
RNSを含む英国規制内ニュース (英語)
Eden Research Plc ("Eden Research" or the "Company")
Director's Shareholding
Eden Research, a leading UK agrochemical development company, announces that Stephen O'Brien, a non-
executive director of the Company, has been issued 47,059 ordinary shares at 42.5p per share, the
closing mid-market price on 9 July 2008. This award of shares is in lieu of Mr O'Brien's fees and he
has agreed to be locked-in for a period of 12 months from the date of issue.
Mr O'Brien holds 47,059 ordinary shares in the Company which represents 0.8% of the Company's issued
share capital.
For further information, please contact:
Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844
Jonathon Brill/Caroline Stewart, Financial Dynamics
T: 020 7831 3113
About Eden Research plc
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development
of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene
chemistry and other patented environmentally friendly technologies. Eden is currently working
alongside universities and partner companies in developing its product portfolio towards
commercialisation.
For further information please visit www.edenresearch.com.
Eden Research plc
Edenville (LSE:EDE)
過去 株価チャート
から 5 2024 まで 6 2024
Edenville (LSE:EDE)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Edenville (ロンドン証券取引所): 0 recent articles
その他のEden Research Plcニュース記事